At Your Service
Roche Canada Your Health Our Products Research Careers
Research Overview
>
Biotechnology
>
Genetics and Genomics
>
Research Fellowship
>
Clinical Trial Applications
>
Research

Thanks to our R&D efforts, Roche has amassed one of the most diverse and comprehensive portfolios for the therapeutic areas we serve, introducing more than 100 drugs to the Canadian marketplace.

Global R&D activities are focused on areas of high unmet medical need. Our highly skilled people discover and develop innovative medicines addressing prevention, diagnosis and therapy to offer physicians and patients integrated healthcare solutions. With our continuous investment in R&D — and by using cutting-edge science and state-of-the-art technology — we will meet tomorrow's healthcare needs.

Areas of global research we engage in include:

  • Anemia
  • Cardiovascular diseases
  • Central nervous system
  • Dermatology
  • Infectious diseases
  • Inflammatory and autoimmune diseases
  • Metabolic disorders
  • Oncology
  • Osteoporosis
  • Paediatrics
  • Respiratory diseases
  • Rheumatoid arthritis
  • Transplantation
  • Virology

We have also partnered with leading Canadian and international biotechnology partners to bring innovative therapies to market.

For more than two decades, our Clinical Research Group has played a pivotal role in Roche's global development programs for new medicines. In 2005, we had 21 compounds in development and more than 2000 patients enrolled in clinical trials in Canada, making us one of the leaders within the Roche global development group. Throughout the years, we have worked extensively with physicians, healthcare institutions and CRO (clinical research operations) partners to advance healthcare opportunities for Canadians in areas such as oncology and rheumatoid arthritis.

About 5,000 scientists around the world are committed to developing new healthcare solutions in crucial therapeutic areas.

In 2003, Roche globally spent 18.3% of its revenue in the Pharmaceuticals Divisions for R&D.

Our research centres are located in:

Basel, Switzerland
Metabolic disorders, central nervous system, vascular diseases

Nutley, USA
Metabolic disorders, oncology, vascular disease

Palo Alto, USA
Central nervous system, inflammatory diseases/bone, genitourinary diseases, viral diseases

Penzberg, Germany
Oncology
 
 
Clear
Research Overview
© 2001-2010 Hoffmann-La Roche Ltd. - Legal Privacy Statement.
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.